BMI View: We expect that Jordan will continue to provide modest opportunities to research-based
pharmaceutical manufacturers. In line with the authorities' efforts to expand healthcare insurance
coverage, we envisage measures aiming to promote the use of cheaper generic medicines, in tandem with
BMI View: Portugal's pharmaceutical and healthcare sector has been transformed since the intervention
of the EU, IMF and ECB as part of the country's EUR78bn economic rescue package approved in May
2011. The latest review states that Portugal has already made considerable savings in the healthcare
BMI View: According to recent reports in The Gulf Times, Qatar will have four new drug manufacturers
by the end of Q113. The drugmakers will reportedly import their raw materials and produce tablets,
syrups and injectables. It is anticipated the drug manufacturers will (in our view eventually) help ...
BMI View: The political instability and underdeveloped economies in many Central American countries
make the region less attractive to multinationals, compared with most neighbouring countries. However,
the heavy reliance on imported medicine in the region provides revenue-generating opportunities f...
BMI View: While it is clear that drugmakers operating in Romania are far from happy with the latest
revisions to the pharmaceutical claw-back tax, and the tax remains unfairly punitive, all things
considered, the August 2012 amendments are a small improvement, though definitely not what producers
BMI View: Our outlook for Hungary's pharmaceutical market remains negative, given the government's
policies that shift the burden of the National Healthcare Fund (OEP) on to drug manufacturers. Pricing
pressure and claw-back taxes have squeezed domestic manufacturers' margins and introduced insecuri...
BMI View: The majority of investment in Zambia's healthcare market stems from international aid
agencies - so the news that the government has increased its allocation for healthcare spending in the
2013 budget will be well received by both NGOs and international investors as a sign that Zambia is
TechNavio's analysts forecast the Global DNA Sequencing Products market to grow at a CAGR of 18.48 percent over the period 2012-2016. One of the key factors contributing to this market growth is the introduction of whole genome sequencing. The Global DNA Sequencing Products market has also been witn...
Dengue Global Clinical Trials Review, H1, 2013
GlobalData's clinical trial report, “Dengue Global Clinical Trials Review, H1, 2013" provides data on the Dengue clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Dengue. It i...
Bone Metastasis Global Clinical Trials Review, H1, 2013
GlobalData's clinical trial report, “Bone Metastasis Global Clinical Trials Review, H1, 2013" provides data on the Bone Metastasis clinical trial scenario. This report provides elemental information and data relating to the clin...